Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care

Cancer remains a major health concern globally. Immune checkpoint inhibitors (ICIs) target co-inhibitory immune checkpoint molecules and have received approval for treating malignancies like melanoma and non-small cell lung cancer. While CTLA-4 and PD-1/PD-L1 are extensively researched, additional t...

Cijeli opis

Bibliografski detalji

Glavni autori:	Yao Xiao, Zi-Zhan Li, Nian-Nian Zhong, Lei-Ming Cao, Bing Liu, Lin-Lin Bu
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2023-12-01
Serija:	Translational Oncology
Teme:	Co-inhibitory immune checkpoint Immune checkpoint inhibitor Biomarker Drug delivery system Immunotherapy
Online pristup:	http://www.sciencedirect.com/science/article/pii/S1936523323001808
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!